News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Funded Gastroenteritis Vaccine for Babies Nearly Here!

Good News for Babies - Funded Gastroenteritis Vaccine Nearly Here!

Soon babies born in New Zealand will be eligible for funded vaccination against rotavirus gastroenteritis caused by rotavirus infection. PHARMAC has funded ROTATEQ® (rotavirus vaccine, live, oral, pentavalent) and added it to the Immunisation Schedule from July 1st. But parents of young babies should be booking their first vaccination visit now as timing for the three-dose vaccine is very important.

Babies born on or after 19th March 2014 are eligible for the newly funded vaccine but only if the first dose is administered before they are 15 weeks old. The final dose must be given before the baby is 8 months old. Where possible ROTATEQ should be given during the current routine immunisation visits at 6 weeks, 3 months and 5 months of age.

Merck Sharp & Dohme, NZ Director, Paul Smith, says, “MSD is proud that 15 years of research and development resulted in the availability of this vaccine for New Zealand infants”.

ROTATEQ is an oral vaccine that is squirted into the baby’s mouth. It helps prevent diarrhoea and vomiting caused by rotavirus infection.

As many parents know, diarrhoea and vomiting in infants and young children can lead to dehydration and a trip to the doctor or hospital. What is less well known is that rotavirus infection is the most common cause of severe gastroenteritis in young children. Almost all children will be infected by rotavirus by five years of age.

Rotavirus is highly contagious and although symptoms vary, those typically associated with rotavirus gastroenteritis include vomiting, fever, abdominal pain and watery diarrhoea, which can last for three to eight days. These symptoms can lead to severe dehydration causing one in every 43 children aged under 5 needing hospital treatment in NZ.

Merck Sharp & Dohme, NZ Director, Paul Smith, adds, “The funding of ROTATEQ is not only great news for our children; but it will also help alleviate the burden on our health care system and on families who have to cope with sick infants. For many parents there is also the concern of time away from work to care for a sick child.”

In one of the largest vaccine trials in history, involving 68,000 infants, RotaTeq reduced the rate of hospitalisations and emergency department visits by 94%, and reduced the number of guardian work days lost by 86%.

ROTATEQ is now available in 100 countries and over 109 million doses have been distributed worldwide. ROTATEQ is used in national programmes in many countries such as Australia, the United States, Austria, Finland, Israel and Belgium.

About MSD
Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A.

Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programmes and partnerships. For more information, visit: www.msd.co.nz

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Photos: Inside The Christchurch Arts Centre Rebuild

Lady Pippa Blake visited Christchurch Arts Centre chief executive André Lovatt, a 2015 recipient of the Blake Leader Awards. The award celebrated Lovatt’s leadership in New Zealand and hisand dedication to the restoration of the Arts Centre. More>>

Running Them Up The Flagpole: Web Tool Lets Public Determine New Zealand Flag

A School of Design master’s student is challenging the flag selection process by devising a web tool that allows the public to feed their views back in a way, he says, the current government process does not. More>>

ALSO:

Survey: ‘The Arts Make My Life Better’: New Zealanders

New Zealanders are creative people who believe being involved in the arts makes their lives better and their communities stronger. Nine out of ten adult New Zealanders (88%) agree the arts are good for them and eight out of ten (82%) agree that the arts help to improve New Zealand society. More>>

ALSO:

Wellington.Scoop: Reprieve For Te Papa Press

Following its review of the role of Te Papa Press, Te Papa has committed to continue publishing books during the museum’s redevelopment, Chief Executive Rick Ellis announced yesterday. More>>

Law Society: Sir Peter Williams QC, 1934 - 2015

“Sir Peter was an exceptional advocate. He had the ability to put the defence case for his clients with powerful oratory. His passion shone through in everything he did and said.” Mr Moore says Sir Peter’s lifelong commitment to prison reform was instrumental in ensuring prison conditions and the rights of prisoners were brought to public attention. More>>

ALSO:

CTU: Peter Conway – Family Statement

Peter committed his whole working life to improving the lives of working people, both in unions and, more recently, as the Economist and Secretary of the Council of Trade Unions. He was previously Chair of Oxfam New Zealand and was on the Board of NZ Trade and Enterprise. More>>

ALSO:

Hundertwasser Art Museum: Whangarei Says Yes

Provisional results confirm Whangarei voted Option B in a landslide result for the Hundertwasser and Wairau Maori Art Centre project. 13,726 voted for the Hundertwasser project in a FPP binding referendum that had higher voter turnout than the last local body election. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news